A Study Evaluating a Proprietary Amino Acid Mixture (Enterade®) in Patients Receiving High-Dose Melphalan Conditioning Followed by Autologous Stem Cell Transplantation for Multiple Myeloma and Non-Hodgkin Lymphoma
Condition(s):Multiple Myeloma; Non-Hodgkin’s LymphomaLast Updated:March 16, 2023Completed